Anti-CD19 CAR-T cell therapy for acquired hemophilia A

被引：0
|
作者：
Schultze-Florey, Christian R. [1 ]
Thol, Felicitas R. [1 ]
Aleksandrova, Krasimira [2 ]
Stoyanov, Kalin [1 ]
Gutierrez Jauregui, Rodrigo [3 ]
Arseniev, Lubomir [2 ]
Leise, Jana [2 ]
Kloess, Stephan [2 ]
Heidel, Florian H. [1 ,2 ,4 ]
Tiede, Andreas [1 ]
机构：
[1] Hannover Med Sch, Hematol Hemostasis Oncol & Stem Cell Transplantat, Hannover, Germany
[2] Hannover Med Sch, Cellular Therapy Ctr, Hannover, Germany
[3] Hannover Med Sch, Inst Immunol, Hannover, Germany
[4] Leibniz Inst Aging, Fritz Lipmann Inst, Jena, Germany
来源：
LEUKEMIA | 2025年
关键词：
D O I：
10.1038/s41375-025-02554-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：980 / 982
页数：3
相关论文
共 50 条
  • [41] Impact of Anti-CD19 CAR-T Axicabtagene Ciloleucel on Vaccine Titers of DTaP and MMR
    Rahman, Zaid Abdel
    Gannon, Nicole
    Melody, Megan
    Muniz, Paul
    Ayala, Ernesto
    Roy, Vivek
    Brumble, Lisa
    Ailawadhi, Sikander
    Sher, Taimur
    Foran, James M.
    Murthy, Hemant S.
    Tun, Han W.
    Rivera, Candido E.
    Chanan-Khan, Asher A.
    Zubair, Abba C.
    Kharfan-Dabaja, Mohamed A.
    BLOOD, 2019, 134
  • [42] Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy
    Wen-ying Zhang
    Yang Liu
    Yao Wang
    Jing Nie
    Ye-lei Guo
    Chun-meng Wang
    Han-ren Dai
    Qing-ming Yang
    Zhi-qiang Wu
    Wei-dong Han
    Gene Therapy, 2018, 25 : 198 - 204
  • [43] MOLECULAR MONITORING OF ANTI-CD19 CAR-T IN PATIENTS WITH B LYMPHOMA BY DIGITAL PCR
    Diego, Carbonell
    Ismael, De la Iglesia
    Silvia, Monsalvo
    Maria, Chicano
    Paula, Muniz
    Rebeca, Bailen
    Gillen, Oarbeascoa
    Mariana, Bastos
    Nieves, Dorado
    Ana, Perez-Corral
    Javier, Anguita
    Mi, Kwon
    Jose Luis, Diez-Martin
    Carolina, Martinez-Laperche
    Ismael, Buno
    HAEMATOLOGICA, 2021, 106 (10) : 16 - 17
  • [44] Overcoming resistance to anti-CD19 CAR T-cell therapy in B-cell malignancies
    Yang, Xingcheng
    Wei, Jia
    Zhou, Jianfeng
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (05) : 821 - 834
  • [45] Characterization of a xenograft model for anti-CD19 CAR T cell studies
    Ahmadbeigi, N.
    Alatab, S.
    Vasei, M.
    Ranjbar, A.
    Aghayan, S.
    Khorsand, A.
    Moradzadeh, K.
    Darvishyan, Z.
    Jamali, M.
    Muhammadnejad, S.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (10): : 2181 - 2190
  • [46] Characterization of a xenograft model for anti-CD19 CAR T cell studies
    N. Ahmadbeigi
    S. Alatab
    M. Vasei
    A. Ranjbar
    S. Aghayan
    A. Khorsand
    K. Moradzadeh
    Z. Darvishyan
    M. Jamali
    S. Muhammadnejad
    Clinical and Translational Oncology, 2021, 23 : 2181 - 2190
  • [47] Predicting Outcomes following Anti-CD19 CAR T Cell Therapy in Aggressive B Cell Lymphomas
    Ho, Carrie
    Svoboda, Jakub
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (03): : 195 - 196
  • [48] Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
    Smith, Melody
    Dai, Anqi
    Ghilardi, Guido
    Amelsberg, Kimberly, V
    Devlin, Sean M.
    Pajarillo, Raymone
    Slingerland, John B.
    Beghi, Silvia
    Herrera, Pamela S.
    Giardina, Paul
    Clurman, Annelie
    Dwomoh, Emmanuel
    Armijo, Gabriel
    Gomes, Antonio L. C.
    Littmann, Eric R.
    Schluter, Jonas
    Fontana, Emily
    Taur, Ying
    Park, Jae H.
    Palomba, Maria Lia
    Halton, Elizabeth
    Ruiz, Josel
    Jain, Tania
    Pennisi, Martina
    Afuye, Aishat Olaide
    Perales, Miguel-Angel
    Freyer, Craig W.
    Garfall, Alfred
    Gier, Shannon
    Nasta, Sunita
    Landsburg, Daniel
    Gerson, James
    Svoboda, Jakub
    Cross, Justin
    Chong, Elise A.
    Giralt, Sergio
    Gill, Saar, I
    Riviere, Isabelle
    Porter, David L.
    Schuster, Stephen J.
    Sadelain, Michel
    Frey, Noelle
    Brentjens, Renier J.
    June, Carl H.
    Pamer, Eric G.
    Peled, Jonathan U.
    Facciabene, Andrea
    van den Brink, Marcel R. M.
    Ruella, Marco
    NATURE MEDICINE, 2022, 28 (04) : 713 - +
  • [49] C-CAR066, a novel fully human anti-CD20 CAR-T therapy for relapsed or refractory large B-cell lymphoma after failure of anti-CD19 CAR-T therapy: A phase I clinical study
    Li, Ping
    Liu, Wei
    Zhou, Lili
    Ye, Shiguang
    Zhu, Dan
    Huang, Jiaqi
    Li, Jing
    Zheng, Chengxiao
    Zhu, Shigui
    Yao, Xin
    Zhu, Kevin
    Yao, Yihong
    Qiu, Lugui
    Liang, Aibin
    Zou, Dehui
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (12) : 2306 - 2312
  • [50] Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
    Melody Smith
    Anqi Dai
    Guido Ghilardi
    Kimberly V. Amelsberg
    Sean M. Devlin
    Raymone Pajarillo
    John B. Slingerland
    Silvia Beghi
    Pamela S. Herrera
    Paul Giardina
    Annelie Clurman
    Emmanuel Dwomoh
    Gabriel Armijo
    Antonio L. C. Gomes
    Eric R. Littmann
    Jonas Schluter
    Emily Fontana
    Ying Taur
    Jae H. Park
    Maria Lia Palomba
    Elizabeth Halton
    Josel Ruiz
    Tania Jain
    Martina Pennisi
    Aishat Olaide Afuye
    Miguel-Angel Perales
    Craig W. Freyer
    Alfred Garfall
    Shannon Gier
    Sunita Nasta
    Daniel Landsburg
    James Gerson
    Jakub Svoboda
    Justin Cross
    Elise A. Chong
    Sergio Giralt
    Saar I. Gill
    Isabelle Riviere
    David L. Porter
    Stephen J. Schuster
    Michel Sadelain
    Noelle Frey
    Renier J. Brentjens
    Carl H. June
    Eric G. Pamer
    Jonathan U. Peled
    Andrea Facciabene
    Marcel R. M. van den Brink
    Marco Ruella
    Nature Medicine, 2022, 28 : 713 - 723
12345